Grand Rounds: ApoB and Lp(a) - The Role of Lipoprotein Biomarkers in the Evaluation and Treatment of Cardiovascular Risk

Penn Presbyterian Medical Center’s Grand Rounds program welcomed George Thanassoulis, MD, the Director of Preventive and Genomic Cardiology at MUHC and an Assistant Professor of Medicine at McGill University. Dr. Thanassoulis discussed the evidence for clinical utility of ApoB testing in primary and secondary prevention, the evidence behind Lp(a), and the implications for cardiovascular specialists with relevant cases. 


May 26, 2022

Created by

Penn Physician VideoLink